QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.106.023705v1 70/4/1461    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stemmle, L. N. Articles by Casey, P. J. Search for Related Content PubMed PubMed Citation Articles by Stemmle, L. N. Articles by Casey, P. J.

The Regulator of G Protein Signaling Domain of Axin Selectively Interacts with G₁₂ but Not G₁₃

Departments of Pathology (L.N.S., T.A.F.) and Pharmacology and Cancer Biology (P.J.C.), Duke University Medical Center, Durham, North Carolina

Axin, a negative regulator of the Wnt signaling pathway, contains a canonical regulator of G protein signaling (RGS) core domain. Herein, we demonstrate both in vitro and in cells that this domain interacts with the subunit of the heterotrimeric G protein G₁₂ but not with the closely related G₁₃ or with several other heterotrimeric G proteins. Axin preferentially binds the activated form of G₁₂, a behavior consistent with other RGS proteins. However, unlike other RGS proteins, that of axin (axinRGS) does not affect intrinsic GTP hydrolysis by G₁₂. Despite its inability to act as a GTPase-activating protein, we demonstrate that in cells, axinRGS can compete for G₁₂ binding with the RGS domain of p115RhoGEF, a known G₁₂-interacting protein that links G₁₂ signaling to activation of the small G protein Rho. Moreover, ectopic expression of axinRGS specifically inhibits G₁₂-directed activation of the Rho pathway in MDA-MB 231 breast cancer cells. These findings establish that the RGS domain of axin is able to directly interact with the subunit of heterotrimeric G protein G₁₂ and provide a unique tool to interdict G₁₂-mediated signaling processes.

Address correspondence to: Timothy A. Fields, Department of Pathology, Duke University Medical Center, Box 3712, Durham, NC 27710. E-mail: taf1{at}duke.edu.

This article has been cited by other articles:

				H. Suzuki, K. Kimura, H. Shirai, K. Eguchi, S. Higuchi, A. Hinoki, K. Ishimaru, E. Brailoiu, D. N. Dhanasekaran, L. N. Stemmle, et al. Endothelial Nitric Oxide Synthase Inhibits G12/13 and Rho-Kinase Activated by the Angiotensin II Type-1 Receptor: Implication in Vascular Migration Arterioscler. Thromb. Vasc. Biol., February 1, 2009; 29(2): 217 - 224. [Abstract] [Full Text] [PDF]

				H. Suzuki, E. D. Motley, K. Eguchi, A. Hinoki, H. Shirai, V. Watts, L. N. Stemmle, T. A. Fields, and S. Eguchi Distinct Roles of Protease-Activated Receptors in Signal Transduction Regulation of Endothelial Nitric Oxide Synthase Hypertension, February 1, 2009; 53(2): 182 - 188. [Abstract] [Full Text] [PDF]

				H. A Kestler and M. Kuhl From individual Wnt pathways towards a Wnt signalling network Phil Trans R Soc B, April 12, 2008; 363(1495): 1333 - 1347. [Abstract] [Full Text] [PDF]

				D. Zhu, R. I. Tate, R. Ruediger, T. E. Meigs, and B. M. Denker Domains Necessary for G{alpha}12 Binding and Stimulation of Protein Phosphatase-2A (PP2A): Is G{alpha}12 a Novel Regulatory Subunit of PP2A? Mol. Pharmacol., May 1, 2007; 71(5): 1268 - 1276. [Abstract] [Full Text] [PDF]